Pain Management for Cancer Surgery
(LapTAP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on long-term opioid or pain medication, you may not be eligible to participate.
What data supports the effectiveness of the treatment Laparoscopic Transversus Abdominis Plane Block for pain management in cancer surgery?
Is the transversus abdominis plane block generally safe for humans?
How is the Laparoscopic Transversus Abdominis Plane Block treatment different from other pain management options for cancer surgery?
The Laparoscopic Transversus Abdominis Plane Block is unique because it involves injecting a local anesthetic between specific abdominal muscles to target sensory nerves, providing pain relief after surgery. This method is guided by a laparoscope (a small camera), allowing precise placement of the anesthetic, which can enhance pain control compared to other techniques.13459
What is the purpose of this trial?
This is a research study to evaluate the effectiveness of 3 different types of routine pain management regimens used during clinically indicated, minimally invasive oncologic (cancer) surgery. This project is considered "Research" and participation is voluntary. Upon enrollment in this study, the research team will collect data from the patient's medical records. The patient will undergo all of the normal testing and procedures required pre-operatively (standard of care). The study team will then randomly assign the patient (like a flip of a coin) to one of three different study arms for pain management during surgery:1. Laparoscopic Transversus Abdominis Plane Block (LapTAP) with Local Anesthetic (LA)2. Laparoscopic Transversus Abdominis Plane Block (LapTAP) only3. Local Anesthetic (LA) only The patient will receive standard pre- and post-operative care according to clinical guidelines (routine care). The study team will collect information from the patient's medical record for the first 24 hours after their surgery and upon discharge. This information will include pain scores, amount of medication required, any side effects the patient may have experienced, and satisfaction with pain control. Participation in the study will end upon discharge from the hospital.
Research Team
Casey Allen, MD
Principal Investigator
Allegheny Health Network
Eligibility Criteria
This trial is for patients with various abdominal cancers (like liver, stomach, pancreatic) who are undergoing minimally invasive surgery. Participants must be eligible for the surgical procedures and willing to have their pain management method chosen randomly.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo minimally invasive oncologic surgery with one of three pain management regimens: LapTAP with LA, LapTAP only, or LA only
Post-operative Monitoring
Participants are monitored for pain scores, opioid consumption, and adverse events for 24 hours post-surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment until discharge
Treatment Details
Interventions
- Laparoscopic Transversus Abdominis Plane Block
- Local Anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Lead Sponsor